CLASS ACTION UPDATE for PPC, UCO and VXRT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / August 26, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

PPC Shareholders Click Here: https://www.zlk.com/pslra-1/pilgrims-pride-corporation-information-request-form?prid=8845&wire=1
UCO Shareholders Click Here: https://www.zlk.com/pslra-1/proshares-ultra-bloomberg-crude-oil-loss-submission-form?prid=8845&wire=1
VXRT Shareholders Click Here: https://www.zlk.com/pslra-1/vaxart-inc-information-request-form-2?prid=8845&wire=1

* ADDITIONAL INFORMATION BELOW *

Pilgrim's Pride Corporation (NASDAQ:PPC)

PPC Lawsuit on behalf of: investors who purchased February 9, 2017 - June 3, 2020
Lead Plaintiff Deadline : September 4, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/pilgrims-pride-corporation-information-request-form?prid=8845&wire=1

According to the filed complaint, during the class period, Pilgrim's Pride Corporation made materially false and/or misleading statements and/or failed to disclose that: (1) the Company and its executives had participated in an illegal antitrust conspiracy to fix prices and rig bids from at least as early as 2012 and continuing through at least early 2017; (2) the Company received competitive advantages, which persisted during the Class Period, from its anticompetitive conduct; and (3) as a result, Defendants' statements about the Company's business, operations, and prospects lacked a reasonable basis.

Proshares Ultra Bloomberg Crude Oil (NYSE:UCO)

UCO Lawsuit on behalf of: investors who purchased March 6, 2020 - April 27, 2020
Lead Plaintiff Deadline : September 28, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/proshares-ultra-bloomberg-crude-oil-loss-submission-form?prid=8845&wire=1

According to the filed complaint, during the class period, Proshares Ultra Bloomberg Crude Oil made materially false and/or misleading statements and/or failed to disclose that: (1) decreased demand for oil due to the coronavirus pandemic and increased oil supply and diminished oil prices caused by the Russia/Saudi oil price war had caused extraordinary market volatility; (2) a massive influx of investor capital into the Fund, totaling hundreds of millions of dollars, in a matter of days had increased Fund inefficiencies, heightened illiquidity in the West Texas Intermediate ("WTI") futures contract markets in which the Fund invested, and caused the Fund to approach positional and regulatory limits (adverse trends exacerbated by the Offering itself); (3) there was a sharp divergence between spot and future prices in the WTI oil markets, leading to a super contango market dynamic as oil storage space in Cushing, Oklahoma dwindled and was insufficient to account for the excess supply expected to be delivered pursuant to the WTI May 2020 futures contract. As a result, UCO could not continue to pursue the passive investment strategy represented in the Registration Statement, causing its results to significantly deviate from its purported benchmark.

Vaxart, Inc. (NASDAQ:VXRT)

VXRT Lawsuit on behalf of: investors who purchased June 25, 2020 - July 25, 2020
Lead Plaintiff Deadline : October 23, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/vaxart-inc-information-request-form-2?prid=8845&wire=1

According to the filed complaint, during the class period, Vaxart, Inc. made materially false and/or misleading statements and/or failed to disclose that: 1) Vaxart exaggerated the prospects of its COVID-19 vaccine candidate, including its purported role or involvement in Operation Warp Speed ('OWS'), a program which commits the federal government to massive funding for the development of COVID-19 vaccines; 2) Vaxart's COVID-19 vaccine candidate had no reasonable prospect for mass production and marketing and was not among the companies chosen to receive significant financial support from OWS to produce hundreds of millions of vaccine doses; and 3) Vaxart's COVID-19 vaccine candidate was merely selected to participate in preliminary U.S. government studies to determine potential areas for possible OWS partnership and support.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP



View source version on accesswire.com:
https://www.accesswire.com/603512/CLASS-ACTION-UPDATE-for-PPC-UCO-and-VXRT-Levi-Korsinsky-LLP-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.